Related references
Note: Only part of the references are listed.Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2022)
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
Mical Paul et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations
Elena Carrara et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Prevalence of polymyxin-induced nephrotoxicity and its predictors in critically ill adult patients: A meta-analysis
Jiang-Lin Wang et al.
WORLD JOURNAL OF CLINICAL CASES (2022)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
Laura Evans et al.
CRITICAL CARE MEDICINE (2021)
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2021)
Less empiric broad-spectrum antibiotics is more in the ICU
Jose Mauro da Fonseca Pestana Ribeiro et al.
INTENSIVE CARE MEDICINE (2020)
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study
Kristina E. Rudd et al.
LANCET (2020)
Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department
Matias Chiarastelli Salomao et al.
EMERGING INFECTIOUS DISEASES (2020)
International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji et al.
PHARMACOTHERAPY (2019)
Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment
Karen P. H. Mattos et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Antibiotic Timing and Outcomes in Sepsis
Richard Y. Kim et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case-control study
W. C. Rottier et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate
M. C. Salomao et al.
JOURNAL OF HOSPITAL INFECTION (2017)
The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study
Flavia R. Machado et al.
LANCET INFECTIOUS DISEASES (2017)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belen Gutierrez-Gutierrez et al.
LANCET INFECTIOUS DISEASES (2017)
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis
Christopher W. Seymour et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Timing of Early Antibiotics and Hospital Mortality in Sepsis
Vincent X. Liu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis
Michail Alevizakos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Manu Shankar-Hari et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Predictive Value of Prior Colonization and Antibiotic Use for Third-Generation Cephalosporin-Resistant Enterobacteriaceae Bacteremia in Patients With Sepsis
Wouter C. Rottier et al.
CLINICAL INFECTIOUS DISEASES (2015)
Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins
M. S. de Oliveira et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control
T. Tangden et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study
Peter M. C. Klein Klouwenberg et al.
CRITICAL CARE (2015)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2013)
Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study
Tjasa Hranjec et al.
LANCET INFECTIOUS DISEASES (2012)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Share Paper
